<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37048757</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>03</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Long-Term Consequences of COVID-19: A 1-Year Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2673</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12072673</ELocationID><Abstract><AbstractText>Long-lasting symptoms after SARS-CoV-2 infection have been described many times in the literature and are referred to as Long COVID. In this prospective, longitudinal, monocentric, observational study, we collected the health complaints of 474 patients (252 ambulatory and 222 hospitalized) at Lausanne University Hospital 1 year after COVID-19 diagnosis. Using a self-reported health survey, we explored cardiopulmonary, vascular, neurological, and psychological complaints. Our results show that age, Charlson comorbidity index, and smoking habits were associated with hospital admission. Regarding the vascular system, we found that having had thromboembolism before SARS-CoV-2 infection was significantly associated with a higher risk of recurrence of thromboembolism at 1 year. In the neurologic evaluation, the most frequent symptom was fatigue, which was observed in 87.5% of patients, followed by "feeling slowed down", headache, and smell disturbance in 71.5%, 68.5%, and 60.7% of cases, respectively. Finally, our cohort subjects scored higher overall in the STAI, CESD, Maastricht, and PSQI scores (which measure anxiety, depression, fatigue, and sleep, respectively) than the healthy population. Using cluster analysis, we identified two phenotypes of patients prone to developing Long COVID. At baseline, CCS score, prior chronic disease, stroke, and atrial fibrillation were associated with Long COVID. During COVID infection, mechanical ventilation and five neurological complaints were also associated with Long COVID. In conclusion, this study confirms the wide range of symptoms developed after COVID with the involvement of all the major systems. Early identification of risk factors associated with the development of Long COVID could improve patient follow-up; nevertheless, the low specificity of these factors remains a challenge to building a systematic approach.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bamps</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armenti</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0009-0008-9356-9402</Identifier><AffiliationInfo><Affiliation>Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bojan</LastName><ForeName>Mirela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anesthesiology, Hopital Marie Lannelongue, 133 Av. de la R&#xe9;sistance, 92350 Le Plessis-Robinson, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grandbastien</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Garnier</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Pneumology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du Pasquier</LastName><ForeName>Renaud</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Service of Neurology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desgranges</LastName><ForeName>Florian</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0409-1689</Identifier><AffiliationInfo><Affiliation>Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papadimitriou-Olivgeris</LastName><ForeName>Matthaios</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alberio</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9686-9920</Identifier><AffiliationInfo><Affiliation>Service of Haematology and Haematology Central Laboratory, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preisig</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5689-4259</Identifier><AffiliationInfo><Affiliation>Service of Psychiatry, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwitter</LastName><ForeName>Jurg</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9966-6149</Identifier><AffiliationInfo><Affiliation>Service of Cardiology, Lausanne University Hospital and University of Lausanne,1011 Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Director CMR Center, University Hospital Lausanne (Centre Hospitalier Universitaire Vaudois (CHUV)), 1011 Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Biology &amp; Medicine, Lausanne University, 1011 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guery</LastName><ForeName>Benoit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>The RegCOVID Study Group</LastName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37048757</ArticleId><ArticleId IdType="pmc">PMC10095027</ArticleId><ArticleId IdType="doi">10.3390/jcm12072673</ArticleId><ArticleId IdType="pii">jcm12072673</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus Disease (COVID-19) Dashboard 2022.  [(accessed on 14 February 2022)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Zhang J.J., Dong X., Cao Y.Y., Yuan Y.D., Yang Y.B., Yan Y.Q., Akdis C.A., Gao Y.D. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2019;75:1730&#x2013;1741. doi: 10.1111/all.14238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14238</ArticleId><ArticleId IdType="pubmed">32077115</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun P., Qie S., Liu Z., Ren J., Li K., Xi J. Clinical characteristics of 50,466 hospitalized patients with 2019-nCoV infection. J. Med. Virol. 2020;92:612&#x2013;617. doi: 10.1002/jmv.25735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25735</ArticleId><ArticleId IdType="pmc">PMC7228255</ArticleId><ArticleId IdType="pubmed">32108351</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X.W., Wu X.X., Jiang X.G., Xu K.J., Ying L.J., Ma C.L., Li S.B., Wang H.Y., Zhang S., Gao H.N., et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series. BMJ. 2019;368:m606. doi: 10.1136/bmj.m606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m606</ArticleId><ArticleId IdType="pmc">PMC7224340</ArticleId><ArticleId IdType="pubmed">32075786</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng P., Zhu H., Witteles R.M., Wu J.C., Quertermous T., Wu S.M., Rhee J.W. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty. Curr. Cardiol. Rep. 2020;22:34. doi: 10.1007/s11886-020-01293-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-020-01293-2</ArticleId><ArticleId IdType="pmc">PMC7189178</ArticleId><ArticleId IdType="pubmed">32350632</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul M.A., Benjamin L., Singh B., Lant S., Michael B.D., Easton A., Kneen R., Defres S., Sejvar J., Solomon T. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767&#x2013;783. doi: 10.1016/S1474-4422(20)30221-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30221-0</ArticleId><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciechanowicz P., Lewandowski K., Szyma&#x144;ska E., Kaniewska M., Rydzewska G.M., Walecka I. Skin and gastrointestinal symptoms in COVID-19. Przegl&#x105;d Gastroenterol. 2020;15:301&#x2013;308. doi: 10.5114/pg.2020.101558.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/pg.2020.101558</ArticleId><ArticleId IdType="pmc">PMC7988824</ArticleId><ArticleId IdType="pubmed">33777269</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Liang W., Jiang M., Guan W., Zhan C., Wang T., Tang C., Sang L., Liu J., Ni Z., et al. Risk Factors of Fatal Outcome in Hospitalized Subjects with Coronavirus Disease 2019 from a Nationwide Analysis in China. Chest. 2015;158:97&#x2013;105. doi: 10.1016/j.chest.2020.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.04.010</ArticleId><ArticleId IdType="pmc">PMC7158802</ArticleId><ArticleId IdType="pubmed">32304772</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Wang X., Jia X., Li J., Hu K., Chen G., Wei J., Gong Z., Zhou C., Yu H., et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin. Microbiol. Infect. 2020;26:767&#x2013;772. doi: 10.1016/j.cmi.2020.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.04.012</ArticleId><ArticleId IdType="pmc">PMC7159868</ArticleId><ArticleId IdType="pubmed">32304745</ArticleId></ArticleIdList></Reference><Reference><Citation>Honigsbaum M., Krishnan L. Taking pandemic sequelae seriously: From the Russian influenza to COVID-19 long-haulers. Lancet. 2020;396:1389&#x2013;1391. doi: 10.1016/S0140-6736(20)32134-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32134-6</ArticleId><ArticleId IdType="pmc">PMC7550169</ArticleId><ArticleId IdType="pubmed">33058777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H., Patel K., Greenwood D., Halpin S., Lewthwaite P., Salawu A., Eyre L., Breen A., O&#x2019;Connor R., Jones A., et al. Long-term Clinical Outcomes in Survivors of Coronavirus Outbreaks after Hospitalisation or ICU Admission: A Systematic Review and Meta-Analysis of Follow-Up Studies. medRxiv. 2020 doi: 10.1101/2020.04.16.20067975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.16.20067975</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. Eclinicalmedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellmuth J., Barnett T.A., Asken B.M., Kelly J.D., Torres L., Stephens M.L., Greenhouse B., Martin J.N., Chow F.C., Deeks S.G., et al. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J. Neurovirol. 2021;27:191&#x2013;195. doi: 10.1007/s13365-021-00954-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00954-4</ArticleId><ArticleId IdType="pmc">PMC7852463</ArticleId><ArticleId IdType="pubmed">33528824</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisicaro F., Napoli M.D., Liberto A., Fanella M., Stasio F.D., Pennisi M., Bella R., Lanza G., Mansueto G. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective. Int. J. Environ. Res. Public Health. 2021;18:1415. doi: 10.3390/ijerph18041415.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18041415</ArticleId><ArticleId IdType="pmc">PMC7913756</ArticleId><ArticleId IdType="pubmed">33546463</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehi S., Reddy S., Gholamrezanezhad A. Long-term Pulmonary Consequences of Coronavirus Disease 2019 (COVID-19) J. Thorac. Imag. 2020;35:W87&#x2013;W89. doi: 10.1097/RTI.0000000000000534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RTI.0000000000000534</ArticleId><ArticleId IdType="pubmed">32404798</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Liu X., Zhou Y., Yu H., Li R., Zhan Q., Ni F., Fang S., Lu Y., Ding X., et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study. Lancet Respir. Med. 2021;9:747&#x2013;754. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>The Writing Committee for the COMEBAC Study Group. Morin L., Savale L., Pham T., Colle R., Figueiredo S., Harrois A., Gasnier M., Lecoq A.-L., Meyrignac O., et al. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. JAMA. 2021;325:1525&#x2013;1534. doi: 10.1001/jama.2021.3331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevinsky J.R., Tao G., Lavery A.M., Kukielka E.A., Click E.S., Malec D., Kompaniyets L., Bruce B.B., Yusuf H., Goodman A.B., et al. Late conditions diagnosed 1&#x2013;4 months following an initial COVID-19 encounter: A matched cohort study using inpatient and outpatient administrative data&#x2014;United States, 1 March&#x2013;30 June 2020. Clin. Infect. Dis. 2021;73:ciab338. doi: 10.1093/cid/ciab338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab338</ArticleId><ArticleId IdType="pmc">PMC8135331</ArticleId><ArticleId IdType="pubmed">33909072</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G.-I., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.-A., Lartey S., Onyango T.B., Kuwelker K., S&#xe6;vik M., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers-Brown J.S., Wanga V., Okoro C., Brozowsky D., Evans A., Hopwood D., Cope J.R., Jackson B.R., Bushman D., Hernandez-Romieu A.C., et al. Outcomes Among Patients Referred to Outpatient Rehabilitation Clinics After COVID-19 diagnosis&#x2014;United States, January 2020&#x2013;March 2021. Morb. Mortal Wkly Rep. MMWR. 2021;70:967&#x2013;971. doi: 10.15585/mmwr.mm7027a2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7027a2</ArticleId><ArticleId IdType="pmc">PMC8312758</ArticleId><ArticleId IdType="pubmed">34237048</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y., Hu P., Guo L., Liu M., Xu J., et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet. 2021;398:747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Sabadia S., Yang D., de Havenon A., Yaghi S., Lewis A., Lord A.S., Melmed K., Thawani S., Balcer L.J., et al. Life stressors significantly impact long-term outcomes and post-acute symptoms 12-months after COVID-19 hospitalization. J. Neurol. Sci. 2022;443:120487. doi: 10.1016/j.jns.2022.120487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120487</ArticleId><ArticleId IdType="pmc">PMC9637014</ArticleId><ArticleId IdType="pubmed">36379135</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers. J. Med. Virol. 2021;93:2555&#x2013;2556. doi: 10.1002/jmv.26624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V. Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab. Syndr. Clin. Res. Rev. 2020;15:145&#x2013;146. doi: 10.1016/j.dsx.2020.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Florencio L.L. Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. Int. J. Environ. Res. Public Health. 2021;18:2621. doi: 10.3390/ijerph18052621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Florencio L.L., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Palacios-Ce&#xf1;a D., Raveendran A.V. Proposed integrative model for post-COVID symptoms. Diabetes Metab. Syndr. Clin. Res. Rev. 2021;15:102159. doi: 10.1016/j.dsx.2021.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.05.032</ArticleId><ArticleId IdType="pmc">PMC8168334</ArticleId><ArticleId IdType="pubmed">34186367</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J., Naylor C.D. The Canadian Cardiovascular Society Grading Scale for Angina Pectoris: Is It Time for Refinements? Ann. Intern. Med. 1992;117:677. doi: 10.7326/0003-4819-117-8-677.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-117-8-677</ArticleId><ArticleId IdType="pubmed">1530200</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuhrer R., Rouillon F. La version fran&#xe7;aise de l&#x2019;&#xe9;chelle CES-D (Center for Epidemiologic Studies-Depression Scale). Description et traduction de l&#x2019;&#xe9;chelle d&#x2019;auto&#xe9;valuation. Psychiatr. Psychobiol. 1989;4:163&#x2013;166. doi: 10.1017/S0767399X00001590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0767399X00001590</ArticleId></ArticleIdList></Reference><Reference><Citation>Radloff L.S. The CES-D Scale: A Self-Report Depression Scale for Research in the General Population. Appl. Psychol. Meas. 1977;1:385&#x2013;401. doi: 10.1177/014662167700100306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/014662167700100306</ArticleId></ArticleIdList></Reference><Reference><Citation>Spielberger C.D., Gorsuch R.L., Lushene R.E. Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press; Polo Alto, CA, USA: 1970.</Citation></Reference><Reference><Citation>Buysse D.J., Reynolds C.F., 3rd, Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatr. Res. 1989;28:193&#x2013;213. doi: 10.1016/0165-1781(89)90047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Appels A., H&#xf6;ppener P., Mulder P. A questionnaire to assess premonitory symptoms of myocardial infarction. Int. J. Cardiol. 1987;17:15&#x2013;24. doi: 10.1016/0167-5273(87)90029-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0167-5273(87)90029-5</ArticleId><ArticleId IdType="pubmed">3666994</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G.R., Chiche J.-D., Coopersmith C.M., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) Spec. Commun. 2016;315:801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer T.T., Ewig S., Marre R., Suttorp N., Welte T., Ggroup T Capnet Study CRB-65 predicts death from community-acquired pneumonia. J. Intern. Med. 2006;260:93&#x2013;101. doi: 10.1111/j.1365-2796.2006.01657.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2006.01657.x</ArticleId><ArticleId IdType="pubmed">16789984</ArticleId></ArticleIdList></Reference><Reference><Citation>McGinley A., Pearse R.M. A national early warning score for acutely ill patients. BMJ Br. Med. J. 2012;345:e5310. doi: 10.1136/bmj.e5310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e5310</ArticleId><ArticleId IdType="pubmed">22875955</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris P.A., Taylor R., Minor B.L., Elliott V., Fernandez M., O&#x2019;Neal L., McLeod L., Delacqua G., Delacqua F., Kirby J., et al. The REDCap Consortium: Building an International Community of Software Platform Partners. J. Biomed. Inf. 2019;95:103208. doi: 10.1016/j.jbi.2019.103208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Firmann M., Mayor V., Vidal P.M., Bochud M., Pecoud A., Hayoz D., Paccaud F., Preisig M., Song K.S., Yuan X., et al. The CoLaus study: A population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc. Disor. 2017;8:6. doi: 10.1186/1471-2261-8-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2261-8-6</ArticleId><ArticleId IdType="pmc">PMC2311269</ArticleId><ArticleId IdType="pubmed">18366642</ArticleId></ArticleIdList></Reference><Reference><Citation>Preisig M., Waeber G., Vollenweider P., Bovet P., Rothen S., Vandeleur C., Guex P., Middleton L., Waterworth D., Mooser V., et al. The PsyCoLaus study: Methodology and characteristics of the sample of a population-based survey on psychiatric disorders and their association with genetic and cardiovascular risk factors. BMC Psychiatr. 2009;9:9. doi: 10.1186/1471-244X-9-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-244X-9-9</ArticleId><ArticleId IdType="pmc">PMC2667506</ArticleId><ArticleId IdType="pubmed">19292899</ArticleId></ArticleIdList></Reference><Reference><Citation>Spielberger . Inventaire d&#x2019;Anxi&#xe9;t&#xe9; Etat-Trait. Les Editions Du Centre de Psychologie Appliqu&#xe9;e; Paris, France: 1993.</Citation></Reference><Reference><Citation>Von Kanel R., Frey K., Fischer J. Independent relation of vital exhaustion and inflammation to fibrinolysis in apparently healthy subjects. Scand. Cardiovasc. J. 2004;38:28&#x2013;32. doi: 10.1080/14017430310015884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14017430310015884</ArticleId><ArticleId IdType="pubmed">15204244</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdi H., Williams L.J. Principal component analysis. Wiley Interdiscip. Rev. Comput. Stat. 2010;2:433&#x2013;459. doi: 10.1002/wics.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wics.101</ArticleId></ArticleIdList></Reference><Reference><Citation>Costello A.B., Osborne J. Best practices in exploratory factor analysis: Four recommendations for getting the most from your analysis recommendations for getting the most from your analysis. Pract. Assess. Res. Eval. 2005;10:1&#x2013;9.</Citation></Reference><Reference><Citation>Kassambara A. Practical Guide to Principal Component Methods in R. STHDA. 2017.  [(accessed on 2 March 2023)]. pp. 17&#x2013;42. Available online:  http://www.sthda.com/english/wiki/practical-guide-to-principal-component-methods-in-r.</Citation></Reference><Reference><Citation>Kassambara A. Practical Guide to Cluster Analysis in R. SHTDA. 2017.  [(accessed on 2 March 2023)].  Available online:  http://www.sthda.com/english/web/5-bookadvisor/17-practical-guide-to-cluster-analysis-in-r?title=practical-guide-to-cluster-analysis-in-r-book.</Citation></Reference><Reference><Citation>Ko J.Y., Danielson M.L., Town M., Derado G., Greenlund K.J., Kirley P.D., Alden N.B., Yousey-Hindes K., Anderson E.J., Ryan P.A., et al. Risk Factors for COVID-19-associated hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System. Clin. Infect. Dis. 2020;72:ciaa1419. doi: 10.1093/cid/ciaa1419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1419</ArticleId><ArticleId IdType="pmc">PMC7543371</ArticleId><ArticleId IdType="pubmed">32945846</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S., Chen S., Li X., Liu S., Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:1421&#x2013;1424. doi: 10.1111/jth.14830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14830</ArticleId><ArticleId IdType="pmc">PMC7262324</ArticleId><ArticleId IdType="pubmed">32271988</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., Arbous M.S., Gommers D.A.M.P.J., Kant K.M., Kaptein F.H.J., van Paassen J., Stals M.A.M., Huisman M.V., et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb. Res. 2020;191:148&#x2013;150. doi: 10.1016/j.thromres.2020.04.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.041</ArticleId><ArticleId IdType="pmc">PMC7192101</ArticleId><ArticleId IdType="pubmed">32381264</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B., Madhavan M.V., Jimenez D., Chuich T., Dreyfus I., Driggin E., Nigoghossian C.D., Ageno W., Madjid M., Guo Y., et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. J. Am. Coll. Cardiol. 2020;75:2950&#x2013;2973. doi: 10.1016/j.jacc.2020.04.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.04.031</ArticleId><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Bobkova P., Spiridonova E., Shikhaleva A., Gamirova A., Blyuss O., Nekliudov N., Bugaeva P., Andreeva M., DunnGalvin A., et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin. Exp. Allergy. 2021;51:1107&#x2013;1120. doi: 10.1111/cea.13997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13997</ArticleId><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 2022;28:2406&#x2013;2415. doi: 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J., Waterboer T., Hippchen T., Simon J., Kirchner M., Lim A., M&#xfc;ller B., Merle U. Persistent symptoms in adult patients one year after COVID-19: A prospective cohort study. Clin. Infect. Dis. 2021;74:ciab611. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A.V., van Zon S.K.R., Olde Hartman T.C., Rosmalen J.G.M., Lifelines Corona Research Initiative Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatr. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Vindegaard N., Benros M.E. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain. Behav. Immun. 2020;89:531&#x2013;542. doi: 10.1016/j.bbi.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7260522</ArticleId><ArticleId IdType="pubmed">32485289</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullins R.J., Meeker T.J., Vinch P.M., Tulloch I.K., Saffer M.I., Chien J.-H., Bienvenu O.J., Lenz F.A. A Cross-Sectional Time Course of COVID-19 Related Worry, Perceived Stress, and General Anxiety in the Context of Post-Traumatic Stress Disorder-like Symptomatology. Int. J. Environ. Res. Public Health. 2022;19:7178. doi: 10.3390/ijerph19127178.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19127178</ArticleId><ArticleId IdType="pmc">PMC9222603</ArticleId><ArticleId IdType="pubmed">35742432</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J., Prats-Uribe A., Feng Q., Wang Y., Gill D., Paredes R., Prieto-Alhambra D. Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19. JAMA Intern. Med. 2022;182:1063&#x2013;1070. doi: 10.1001/jamainternmed.2022.3858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2022.3858</ArticleId><ArticleId IdType="pmc">PMC9389434</ArticleId><ArticleId IdType="pubmed">35980616</ArticleId></ArticleIdList></Reference><Reference><Citation>The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Shankar-Hari M., Vale C.L., Godolphin P.J., Fisher D., Higgins J.P.T., Spiga F., Savovic J., Tierney J., Baron G., et al. Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19. JAMA. 2021;326:499&#x2013;518. doi: 10.1001/jama.2021.11330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11330</ArticleId><ArticleId IdType="pmc">PMC8261689</ArticleId><ArticleId IdType="pubmed">34228774</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>